Ahlemeyer, B., Selke, D., Schaper, C., Klumpp, S., & Krieglstein, J. (2001). Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. European Journal of Pharmacology, 430, 1—7.

Blumenthal, M. (2000). Market report. Herbalgram, 51, 69.

Chan, P. C., Xia, Q., & Fu, P. P. (2007). Ginkgo biloba leaf extract: biological, medicinal, and toxicological effects. Journal of Environmental Science and Health, Part C, 25, 211—244.

Guinot, P., & Braquet, P. (1994). Effects of the PAF antagonists, ginkgolides (bn-52063, bn-52021), in various clinical indications. Journal of Lipid Mediators and Cell, 10, 141—146.

Hecker, H., Johannisson, R., Koch, E., & Siegers, C. P. (2002). In vitro evaluation of the cytotoxic, potential of alkylphenols from Ginkgo biloba L. Toxicology, 177, 167—177.

Hori, S., & Hori, T. (1997). A cultural history of Ginkgo biloba in Japan and the generic name Ginkgo. In T. Hori, R. W. Ridge, W. Tulecke, P. Del Tredici, J. Tremouillaux-Giller, & H. Tobe (Eds.), Ginkgo Biloba — A global treasure (pp. 385—411). Tokyo, Japan: Springer-Verlag.

Kastner, U., Hallmen, C., Wiese, M., Leistner, E., & Drewke, C. (2007). The human pyridoxal kinase, a plausible target for ginkgotoxin from Ginkgo biloba. FEBS Journal, 274, 1036—1045.

Mahadevan, S., & Park, Y. (2008). Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. Journal of Food Science, 73, R14—19.

Miyakawa, T. (2007). Structure—function analysis of antifungal protein from ginkgo seeds. PhD thesis. University of Tokyo. pp. 20—42.

Miyakawa, T., Miyazono, K., Sawano, Y., Hatano, K., & Tanokura, M. (2009). Crystal structure of ginkbilobin-2 with homology to the extracellular domain of plant cysteine-rich receptor-like kinases. Proteins, 77, 247—251.

Pan, W., Luo, P., Fu, R., Gao, P., Long, Z., Xu, F., et al. (2006). Acaricidal activity against Panonychus citri of a ginkgolic acid from the external seed coat of Ginkgo biloba. Pest Management Science, 62, 283 —287.

Sawano, Y., Miyakawa, T., Yamazaki, H., Tanokura, M., & Hatano, K. (2005). Purification, characterization, and molecular cloning of an antifungal protein gene from Ginkgo biloba seeds. Biological Chemistry, 388, 273—280.

Sawano, Y., Hatano, K., Miyakawa, T., Komagata, H., Miyauchi, Y., Yamazaki, H., et al. (2008). Proteinase inhibitor from ginkgo seeds is a member of plant nonspecific lipid transfer protein gene family. Plant Physiology, 146, 1909—1919.

Singh, B., Kaur, P., Gopichand, Singh, R. D., & Ahuja, P. S. (2008). Biology and chemistry of Ginkgo biloba. Fitoterapia, 79, 401—418.

Thompson, C. B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.

Vaughn, K. C., & Renzaglia, K. S. (2006). Structural and immunocytochemical characterization of the Ginkgo biloba L. sperm motility apparatus. Protoplasma, 227, 165-173.

Wada, K., Ishigaki, S., Ueda, K., Sakata, M., & Haga, M. (1985). An antivitamin B6, 4'-O-methoxypyridoxine, from the seed of Ginkgo biloba L. Chemical & Pharmaceutical Bulletin, 33, 3555-3557.

Wang, H., & Ng, T. B. (2000). Ginkbilobin, a novel antifungal protein from Ginkgo biloba seeds with sequence similarity to embryo-abundant protein. Biochemical and Biophysical Research Communications, 279, 407-411.

Ye, X. Y., Wang, H. X., & Ng, T. B. (2000a). Dolichin, a new chitinase-like antifungal protein isolated from field beans (Dolichos lablab). Biochemical and Biophysical Research Communications, 269, 155-159.

Ye, X. Y., Wang, H. X., & Ng, T. B. (2000b). Structurally dissimilar proteins with antiviral and antifungal potency from cowpea (Vigna unguiculata) seeds. Life Sciences, 67, 3199-3207.

Therapeutic Effects of Grains of Paradise (Aframomum melegueta) Seeds

Solomon Umukoro, Aderemi Caleb Aladeokin

Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria


Introduction 535 Botanical Description 536 Historical Cultivation and Usage 537

Present-Day Cultivation and Usage 538

Applications to Health Promotion and Disease Prevention 538 Adverse Effects and Reactions (Allergies and Toxicity) 541 Summary Points 542 References 542


AM, Aframomum melegueta

ASA, acetylsalicylic acid

CNS, central nervous system

COX-2, cyclo-oxgenase-2

FDA, Food and Drug Administration

GP, grain of paradise

MDA, malonyldialdehyde

NSAIDs, non-steriodal anti-inflammatory drugs

PHZ, phenylhydrazine

PW, paw withdrawal

RA, rheumatoid arthritis

WBC, white blood cell

Was this article helpful?

0 0
Health And Fitness 101

Health And Fitness 101

Self-improvement is a thing which you must practice throughout your life because once you started to believe that you are perfect then, things will start to become complex. You need to know that no one is perfect and no one can be perfect.

Get My Free Ebook

Post a comment